The A-share brain engineering concept continues to strengthen, with Innovative Medical hitting the limit up, and DNAKE, BeiYikang, UCloud, APON, ZKTECO, Stonehill Technology, and others following suit

DNAKE: Transferred 40% equity of its subsidiary and waived preemptive rights for capital increase

DNAKE announced that the company intends to transfer 40% equity of its wholly-owned subsidiary, Xiamen DNAKE Intelligent Transportation Technology Co., Ltd., to Guangzhou Shujin Hulian Technology Co., Ltd. for RMB 4 million. After the equity transfer is completed, Intelligent Transportation plans to increase its registered capital by RMB 6 million, which will be subscribed by Shujin Hulian for RMB 6 million, and the company will waive its preferential subscription rights. After the completion of this transaction, the company's shareholding ratio in Intelligent Transportation will change from 100% to 37.50%, and Intelligent Transportation will no longer be included in the company's consolidated financial statements

DNAKE: Net profit loss of 2.2296 million yuan in the first half of 2025

DNAKE announced that its operating revenue in the first half of 2025 was 284 million yuan, a year-on-year decrease of 14.53%. The net loss attributable to shareholders of the listed company was 2.2296 million yuan, compared to a net profit of 25.9823 million yuan in the same period last year

DNAKE unveils H618 Pro 10.1" Indoor Monitor, running on Android 15 OS, for smart intercom sys. - Xiamen, China, Aug 18, 2025.

In Xiamen, China on August 18, 2025, DNAKE, a top IP video intercom and smart home system company, introduced the H618 Pro 10.1" Indoor Monitor. It is the first in the smart intercom sector to be powered by the Android 15 operating system. This cutting-edge device is designed for use in residential settings and offers advanced features.

04:19 ET DNAKE Emerges as a Global Innovator in Brain-Computer Interface Technology

DNAKE is emerging as a leader in Brain-Computer Interface (BCI) technology, which is transforming human-machine interaction. The global BCI market is projected to grow from $1.74 billion in 2022 to $3.3 billion by 2027, driven by healthcare applications and neurological disorder treatments. DNAKE's strategic partnerships with top research institutions and its role in standardization efforts position it for global influence. Recent innovations include a Human-AI Multi-agent Copilot system and advancements in sleep-stage classification. With a commitment to R&D, DNAKE aims to shape the future of BCI technology.